Cargando…
Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
The role of the androgen receptor (AR) signaling axis in the progression of prostate cancer is a cornerstone to our understanding of the molecular mechanisms causing castration-resistant prostate cancer (CRPC). Resistance of advanced prostate cancer to available treatment options makes it a clinical...
Autores principales: | Kahn, Barbara, Collazo, Joanne, Kyprianou, Natasha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062951/ https://www.ncbi.nlm.nih.gov/pubmed/24948871 http://dx.doi.org/10.7150/ijbs.8671 |
Ejemplares similares
-
Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance
por: Archer, Maddison, et al.
Publicado: (2020) -
Profiling Prostate Cancer Therapeutic Resistance
por: Wade, Cameron A., et al.
Publicado: (2018) -
Inflammation in prostate cancer progression and therapeutic targeting
por: Stark, Timothy, et al.
Publicado: (2015) -
Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Jacob, Aasems, et al.
Publicado: (2021) -
Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)